Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4525618

CNc1nc(N)nc2cc(-c3ccccc3)ccc12.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 4/20 0.52
TRIM58 Q8NG06 1/20 0.49
PTPN1 P18031 5/20 0.45
HRH4 Q9H3N8 2/20 0.45
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CLK4 Q9HAZ1 2/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
CYP2C9 P11712 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TARS1 P26639 1/20 0.40
MAP4K4 O95819 1/20 0.40
APP P05067 2/20 0.39
CCNE2 O96020 1/20 0.39
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
NLRP3 Q96P20 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4528549 0.98 DHFR (0.50) DHFRTRIM58PTPN1HRH4CYP1A2
Trifluoroacetic Acid SCHEMBL4526540 0.92 PTPN1 (0.48) DHFRTRIM58PTPN1CYP1A2CYP3A4
Trifluoroacetic Acid SCHEMBL4529413 0.89 DHFR (0.40) DHFRTRIM58PTPN1HRH4CYP1A2
SCHEMBL4528809 0.89 DHFR (0.65) DHFRTRIM58PTPN1HRH4CYP1A2
Trifluoroacetic Acid SCHEMBL4527903 0.88 DHFR (0.43) DHFRTRIM58PTPN1TARS1MAP4K4
Trifluoroacetic Acid SCHEMBL4526781 0.88 DHFR (0.43) DHFRTRIM58PTPN1HRH4TARS1
Trifluoroacetic Acid SCHEMBL4521203 0.88 DHFR (0.43) DHFRTRIM58PTPN1HRH4TARS1
Trifluoroacetic Acid SCHEMBL4528055 0.87 MAP4K4 (0.43) DHFRTRIM58PTPN1MAP4K4NLRP3
Trifluoroacetic Acid SCHEMBL4524000 0.87 CYP1A2 (0.52) DHFRHRH4CYP1A2CYP3A4CLK4
Trifluoroacetic Acid SCHEMBL4533807 0.87 MAP4K4 (0.47) DHFRHRH4TP53MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101056865-A Aminoquinazolines compounds HOFFMANN LA ROCHE (CH) 2007-10-17 CN claimed
EP-1812409-A1 AMINOQUINAZOLINES COMPOUNDS F. Hoffmann-Roche AG (CH) 2007-08-01 EP claimed
WO-2006050843-A1 AMINOQUINAZOLINES COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2006-05-18 WO claimed
US-20090105477-A1 Quinazoline Protein Tyrosine Phosphatase Inhibitors BERTHEL STEVEN JOSEPH 2009-04-23 US disclosed
CN-101056865-A Aminoquinazolines compounds HOFFMANN LA ROCHE (CH) 2007-10-17 CN disclosed
EP-1812409-A1 AMINOQUINAZOLINES COMPOUNDS F. Hoffmann-Roche AG (CH) 2007-08-01 EP disclosed
US-20060211715-A1 Quinazoline protein tyrosine phosphatase inhibitors BERTHEL STEVEN J 2006-09-21 US disclosed
WO-2006050843-A1 AMINOQUINAZOLINES COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105477-A1 Quinazoline Protein Tyrosine Phosphatase Inhibitors PTPN5, PTPN1, PTPN7 DHFR 2071/4885TRIM58 2337/4885PTPN1 2/4885
US-20060211715-A1 Quinazoline protein tyrosine phosphatase inhibitors PTPN5, PTPN1, PTPN7 DHFR 2071/4885TRIM58 2337/4885PTPN1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.